SB 5704
In CommitteeSenate
Health care marketplace
Concerning material changes to the operations and governance structure of participants in the health care marketplace.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill creates a new state-level review process for major health care mergers, acquisitions, and affiliations to ensure they do not reduce access, affordability, or equity in care—especially for reproductive, end-of-life, and gender-affirming services. It requires advance notice, public hearings, and a detailed assessment of impacts before the attorney general can approve or block a transaction.
- Requires health care entities (hospitals, hospital systems, provider organizations, and insurers) to submit 90 days’ advance notice to the attorney general and health care authority before completing mergers, acquisitions, or new contracting affiliations.
- Establishes a dual review process: the health care authority conducts an access, affordability, quality, and equity review (including public hearings), and the attorney general evaluates whether the transaction violates antitrust laws or harms access to care.
- Prohibits transactions that would reduce access to essential services—including reproductive care, end-of-life care, and gender-affirming care—or worsen health disparities, especially in rural or underserved areas.
- Requires the attorney general to approve, approve with conditions, or disapprove transactions based on whether they meet specific public interest standards, such as maintaining or improving access for Medicaid patients, low-income individuals, and marginalized groups.
- Mandates 5 years of post-transaction monitoring, including annual reporting, on-site audits, and public comment opportunities, with penalties for noncompliance.
- Allows for expedited review in emergencies (e.g., threats to health care access), and provides a path for public appeals and judicial review of decisions.
Who is affected
- Health care providers and systems — Hospitals, hospital systems, and provider organizations must submit detailed notices before merging, acquiring, or forming new contracting affiliations, and may be required to meet specific conditions to maintain access to care.
- Patients and community members — Patients and communities may see changes in availability of services like reproductive, end-of-life, and gender-affirming care, depending on whether approved transactions meet access and equity requirements.
- State agencies (Attorney General and Health Care Authority) — State agencies—the attorney general and health care authority—gain new authority to review and conditionally approve or reject health care transactions, and to monitor long-term compliance.
- Medically underserved and marginalized populations — Low-income, rural, and marginalized populations—including Medicaid recipients, uninsured individuals, and gender-diverse people—are specifically protected under the bill’s access and equity standards.
- Health insurers and carriers — Insurance carriers and health plans must be notified of certain transactions and may be involved in reviews when health systems merge with insurers or holding companies.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
The bill explicitly prohibits transactions that reduce access to reproductive, end-of-life, and gender-affirming care—services historically vulnerable to cuts post-merger. By requiring a formal access, affordability, quality, and equity review—including community input and specific assessment of marginalized populations (e.g., Medicaid recipients, LGBTQ+ individuals, rural residents)—the bill creates a legally enforceable safeguard against service reductions. This is especially important in a post-Roe environment where reproductive and gender-affirming care are politically targeted and at risk of being deprioritized by for-profit systems.
HealthcarePeopleRef: Sec. 9(1), Sec. 12(3)(c), Sec. 12(3)(e)The bill mandates 5 years of post-transaction monitoring, including annual reporting, on-site audits, and public comment opportunities. This long-term oversight helps ensure that initial promises (e.g., maintaining rural clinics, preserving Medicaid access) are kept, rather than being abandoned once the merger is complete. This is a significant upgrade over current practice, where post-merger monitoring is rare and unenforceable, allowing systems to renege on community benefit commitments with little consequence.
HealthcarePeopleRef: Sec. 10(5)(b), Sec. 14(2), Sec. 14(3)The bill requires assessment of health disparities and historical inequities, with explicit focus on medically underserved groups (e.g., racial/ethnic minorities, LGBTQ+ people, people with disabilities, low-income individuals). By mandating that health systems demonstrate how a transaction will *reduce* disparities—or at least not worsen them—the law creates a tool to counteract market forces that tend to concentrate high-cost, high-margin services in affluent areas while deprioritizing safety-net care. This is a direct intervention to advance health equity in a state with persistent gaps in outcomes.
HealthcarePeopleRef: Sec. 9(2)(b), Sec. 12(3)(b), Sec. 12(3)(h)The bill requires public hearings with multilingual notice (English, Spanish, and three other local languages) and mandates community engagement—including input from employee reps, health advocates, and residents. This increases transparency and democratic accountability in health system decisions that directly affect local services, jobs, and care quality. While not a direct service improvement, it empowers communities to influence health system changes that affect their daily lives, especially in areas with historically low civic engagement.
Public SafetyPeopleRef: Sec. 11(2), Sec. 12(1)The bill authorizes civil penalties (up to 10% of transaction value for noncompliance, 1% per day for failure to comply with conditions) and allows recovery of monitoring costs from affected parties. While this creates financial accountability, the *primary* benefit is to the public: it deters bad-faith transactions and ensures violators—not taxpayers—bear the cost of enforcement. This is especially valuable for Medicaid-dependent populations, who rely on stable, equitable access to care and would otherwise suffer when systems cut services post-merger.
FinancialLean peopleRef: Sec. 14(10), Sec. 16
Potential Concerns (5)
The bill may delay or block clinically necessary health care transactions (e.g., hospital closures in rural areas, system consolidations to maintain services), potentially worsening access in underserved regions if no alternative provider remains. While the goal is to protect services, the rigid “no reduction in access” standard—without explicit allowance for unavoidable service reductions due to financial unsustainability—could prevent rational system reorganization, especially in areas with declining populations or workforce shortages. This could leave communities with under-resourced, overburdened facilities rather than enabling smarter, coordinated care models. This risk is highest in rural and small-district hospitals that lack scale to absorb losses but face closure without consolidation.
HealthcarePeopleRef: Sec. 9(1), Sec. 10(5)(c), Sec. 14(9)The bill imposes significant ongoing compliance costs on health systems—up to 5 years of monitoring, annual reporting, audits, and potential penalties (up to 1% of transaction value per day for noncompliance). While fees and penalties are designed to recover costs, small and mid-sized systems (e.g., community hospitals, rural clinics) may struggle with administrative burden, especially if they lack legal or compliance staff. This could incentivize consolidation *away* from small players toward large systems that can absorb compliance costs, indirectly reducing competition over time.
FinancialPeopleRef: Sec. 14(5), Sec. 14(9)The bill’s requirement that conditions/modifications must bear a “direct and rational relationship” to the transaction and Section 9 standards may limit the attorney general’s ability to impose broad structural remedies (e.g., divestiture, firewalls, service mandates) that are often needed to mitigate anticompetitive or equity harms from large mergers. In practice, this could result in weak or unenforceable conditions (e.g., vague “maintain access” promises without metrics), reducing the bill’s effectiveness in preventing harm. This is especially problematic for complex, multi-system mergers where downstream effects are hard to predict or remediate post-hoc.
HealthcarePeopleRef: Sec. 10(5)(b), Sec. 14(8)The bill explicitly states that attorney general approval under this law does *not* bar subsequent antitrust or consumer protection enforcement under RCW 19.86. While this preserves legal flexibility, it creates potential for overlapping or conflicting oversight (e.g., attorney general approving a merger under equity/access standards, then later pursuing a separate antitrust case). This could increase legal uncertainty and transaction delays for providers, though it does not directly harm public safety.
Public SafetyRef: Sec. 10(5)(a), Sec. 16The bill’s post-transaction monitoring and enforcement mechanism (e.g., investigations, public notice, civil fines) is robust on paper but depends heavily on agency staffing and resources. If the attorney general and health care authority lack sufficient staff to conduct audits, respond to complaints, or pursue violations, the law’s deterrent effect may be weak—especially against well-resourced health systems that can absorb fines. This risk is not unique to this bill but is structural to enforcement-based regulation.
HealthcareRef: Sec. 14(7), Sec. 14(9)
Who Is Most Affected
Large health systems (e.g., Providence, Kaiser, MultiCare) will face significant new administrative and legal burdens, including 90-day advance notice, detailed disclosures, public hearings, and 5 years of monitoring. While they may absorb costs, the risk of disapproval or costly conditions could deter mergers that would otherwise proceed, potentially slowing consolidation but also reducing economies of scale.
Rural and small-town hospitals—especially those with thin margins—may benefit from protections against being acquired and stripped of services, but could be harmed if the bill prevents necessary consolidations that would stabilize them (e.g., joining a larger system to share resources). The 50% Medicaid revenue threshold in Sec. 4(2) may help some safety-net providers, but the overall burden could outweigh benefits for under-resourced systems.
Patients in underserved areas (e.g., Medicaid recipients, LGBTQ+ individuals, rural communities) are the primary intended beneficiaries: the bill explicitly protects access to reproductive, end-of-life, and gender-affirming care and requires reduction of health disparities. However, if the bill inadvertently blocks *all* mergers (including those that would improve access), some communities could lose services entirely.
State agencies (Attorney General, Health Care Authority) gain new authority and responsibility but also significant workload. They will need to hire legal, clinical, and compliance staff to manage reviews, hearings, and 5-year monitoring. Funding through fees and penalties is intended to cover costs, but underfunding could weaken enforcement.
Health insurers and employers (as health plan sponsors) may benefit from more stable, predictable service networks post-merger, but could face higher costs if the bill blocks consolidations that reduce administrative overhead. The focus on affordability in Sec. 9(2)(a) may pressure systems to control pricing, but the bill does not directly regulate premiums or provider rates.